3 In the largest phase 3a trial, STEP 1, results showed that patients taking Wegovy achieved a mean weight loss of 15 per cent (15 kg) sustained over 68 weeks
On the lowest regular doses, some patients are still losing too much weight
As a peptide-based triple agonist, retatrutide is likely to be sensitive to environmental factors including temperature, light, and physical agitation as is the case with other injectable peptide medicines
Steady daily dosing is the standard
Long-Term Metabolic Impact Surgery induces metabolic changes that improve insulin sensitivity, reduce inflammation, and reset the bodys weight set point. These effects are longer-lasting and more profound than those from medication alone
Stay Hydrated : Adequate hydration can support overall skin health and reduce discomfort